Deciphering the modifiers for phenotypic variability of X-linked adrenoleukodystrophy

World Journal of Biological Chemistry
Shruti V PalakuzhiyilSadanandavalli Retnaswami Chandra

Abstract

X-linked adrenoleukodystrophy (X-ALD), an inborn error of peroxisomal β-oxidation, is caused by defects in the ATP Binding Cassette Subfamily D Member 1 (ABCD1) gene. X-ALD patients may be asymptomatic or present with several clinical phenotypes varying from severe to mild, severe cerebral adrenoleuko-dystrophy to mild adrenomyeloneuropathy (AMN). Although most female heterozygotes present with AMN-like symptoms after 60 years of age, occasional cases of females with the cerebral form have been reported. Phenotypic variability has been described within the same kindreds and even among monozygotic twins. There is no association between the nature of ABCD1 mutation and the clinical phenotypes, and the molecular basis of phenotypic variability in X-ALD is yet to be resolved. Various genetic, epigenetic, and environmental influences are speculated to modify the disease onset and severity. In this review, we summarize the observations made in various studies investigating the potential modifying factors regulating the clinical manifestation of X-ALD, which could help understand the pathogenesis of the disease and develop suitable therapeutic strategies.

References

Jan 1, 1992·Journal of Inherited Metabolic Disease·H W MoserW Krivit
Mar 1, 1989·Journal of Neurology, Neurosurgery, and Psychiatry·G M ElringtonN F Lawton
Sep 1, 1987·Journal of Neurology, Neurosurgery, and Psychiatry·R H SimpsonC J Reinecke
Nov 13, 1995·Biochemical and Biophysical Research Communications·J BergerG Fischer
Sep 1, 1995·Journal of Neuroimmunology·M C McGuinnessK D Smith
Jul 1, 1997·Journal of Neurology, Neurosurgery, and Psychiatry·B M van GeelP G Barth
May 5, 1999·Neurochemical Research·K D SmithP A Watkins
Apr 5, 2000·Journal of Neuropathology and Experimental Neurology·J M PowersH W Moser
Nov 7, 2000·Journal of Neuroimmunology·M Gomez-LiraA Salviati
Mar 21, 2001·Nature Reviews. Genetics·J H Nadeau
Aug 15, 2002·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Chang J HuangJean de Vellis
Sep 5, 2002·Annals of Neurology·Eli HershkovitzEsther Manor
Oct 29, 2002·Annals of Neurology·Esther M MaierAdelbert A Roscher
Jan 27, 2005·Molecular Genetics and Metabolism·Stephan KempRonald J A Wanders
Apr 1, 2005·Human Molecular Genetics·Muriel AsheuerPatrick Aubourg
Mar 8, 2007·Nature Clinical Practice. Neurology·Hugo W MoserGerald V Raymond
Oct 7, 2008·Biochemical and Biophysical Research Communications·Esther M MaierJohannes Berger
Mar 17, 2010·Neurology India·Jayaprakash Gosalakkal, Anand Prasad Balky
Jul 16, 2010·Brain Pathology·Stephan Kemp, Ronald Wanders
Feb 23, 2011·Arquivos brasileiros de endocrinologia e metabologia·Fernanda Caroline SoardiMaricilda Palandi de Mello
Jun 7, 2011·Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics·Guang-na CaoXi-ru Wu
Nov 25, 2011·Molecular Genetics and Metabolism·Parastoo JangoukGerald V Raymond
Jan 6, 2012·Journal of Neurology·Rebecca Deering BroseKirby D Smith
May 25, 2012·Nature·Robert D BellBerislav V Zlokovic
Dec 10, 2013·Biochimie·J BergerF S Eichler
Apr 23, 2014·Biomolecules & Therapeutics·Takayuki Sassa, Akio Kihara
Jul 24, 2014·The Application of Clinical Genetics·Sabina Gallati
Sep 18, 2015·Brain : a Journal of Neurology·Patricia L MusolinoFlorian S Eichler
Nov 6, 2015·Neurology·Floriane BouquetCéline Louapre
Dec 22, 2015·Clinica Chimica Acta; International Journal of Clinical Chemistry·Fakhri KallabiHassen Kamoun

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenoleukodystrophy

Adrenoleukodystrophy (ALD), the most frequent peroxisomal disorder, is an X-linked disorder caused by a defect in the metabolism of long chain fatty acids leading to demyelination, neurodegeneration, and death. Here is the latest research.